Home
Products
Learn
About
Pricing
Log In
BODN

This asset is not currently listed on any markets available through Pearler. The information on this page may be inaccurate or out of date.

Asset Logo

BOD Australia Limited

🇦🇺 ASX

👑 Overview

📈 Performance

💵 Cost

🍃 Esg

🤓 Advanced

👨‍👩‍👧‍👦 Community

📈

N/A
Annual Growth

5 years average annual capital growth

💵

$ 500
Minimum Order

Due to regulatory requirements

🌏

2
Pearlers Invested

Since January 2020

👑 Overview

Key information
🔎 Fund Overview

BOD Australia Limited - Ordinary Fully Paid Deferred

📈 Performance

Price History

N/A

1M

All Time

Graph

Table

Unsure how much or often to invest?
🗓️ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out →
💵 Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out →
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out →

💵 Costs

💵

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

💼

N/A
Management Fee

Included in unit price, not charged by Pearler

💸

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator

🤓 Advanced information

Technical Info

👩‍👩‍👦 Community Insights

How our community is investing

🌏 Pearlers invested in BODN

0

📊 Total Capital Earnings

N/A

🔃 Average investment frequency

N/A

💵 Average investment amount

N/A

Last time a customer invested in BODN

N/A
BODN investor breakdown
💵 Income of investors

More than 200k

150k - 200k

100k - 150k

50k - 100k

Less than 50k

👶 Age of investors

18 - 25

26 - 34

35 - 90

🙋 Legal gender of investors

Female

Male

Pearlers who invest in BODN also invest in...

SPDR S&P/ASX 200 Fund

STW

STW.AX was created on 2001-08-24 by SPDR. The fund's investment portfolio concentrates primarily on large cap equity. The ETF currently has 4827.93m in AUM and 203 holdings. The SPDR S&P/ASX 200 Fund, seeks to closely match, before fees and expenses, the returns of the S&P/ASX 200 Index.

📊 Share price

$65.79 AUD

NULL AUSTRALIA

NULL OTHER

NULL BETA

NULL INDEX

Find Out More

Cann Group Ltd. operates research and development and cultivation facilities to grow medicinal cannabis. The company is headquartered in Melbourne, Victoria. The company went IPO on 2017-05-04. The principal activities of the Company include the cultivation of medicinal cannabis for both medicinal and research purposes pursuant to the licenses and permits issued to the group, the development and manufacture (via third party arrangements) of finished product formulations, and the pursuit and execution of various supply agreements with third parties. The firm supplies a range of dried flower and oil products, as well as active pharmaceutical ingredients and extracts, to customers in Australia and around the world. The company also owns Satipharm and its patent-protected capsule technology. The firm's research, cultivation and good manufacturing practices (GMP) manufacturing facilities are located in Melbourne, and a cultivation and GMP manufacturing facility is near Mildura, Victoria.

📊 Share price

$0.17 AUD

Goodman Group engages in the development, owning, and management of industrial property and business space. The company is headquartered in Rosebery, New South Wales and currently employs 950 full-time employees. The company went IPO on 2005-02-02. The firm owns, develops, and manages properties. The principal activities of the Company are investment in directly and indirectly held industrial property, investment management, property management services and development management. Its segments include Asia (Greater China (including the Hong Kong SAR) and Japan), Continental Europe and the United Kingdom. The activities and services undertaken by the segments include property investment, comprising its investments in partnerships; management activities, both fund and property management; and development activities, including development of directly owned assets and management of development activities for partnerships. The firm consists of stapled entities, including Goodman Limited, Goodman Industrial Trust and Goodman Logistics (HK) Limited.

📊 Share price

$20.22 AUD

NOVONIX Ltd. is an integrated developer and supplier of materials, equipment and services for the global lithium-ion battery industry with operations in the U.S. and Canada. The company is headquartered in Brisbane, Queensland. The company went IPO on 2015-12-02. The firm provides advanced materials, equipment, and services for the global lithium-ion battery industry with sales in approximately 14 countries. The company operates through three segments: Graphite Exploration and Mining, Battery Technology, and Battery Materials. The Battery Materials segment develops and manufactures battery anode materials. The Battery Technology segment develops battery cell testing equipment, carries out consulting services and research and development in battery technologies. Its products include ultra-high precision coulometry cyclers and thermal chambers. The company has developed a new environmentally friendly process to produce graphite anode material for lithium-ion batteries in the United States. Battery Materials and Battery Technology are carried out in North America and all segment activities relating to Graphite Exploration and Mining are carried out in Australia.

📊 Share price

$0.94 AUD

Pilbara Minerals Ltd. engages in the exploration and evaluation of mineral properties. The company is headquartered in Perth, Western Australia and currently employs 446 full-time employees. The company went IPO on 2007-09-19. The firm is primarily engaged in the exploration, development, and mining of minerals in Australia. Its 100% owned Pilgangoora hard-rock lithium operation is located approximately 120 kilometers (kms) from Port Hedland in Western Australia’s resource-rich Pilbara region. The operation consists of two processing plants: the Pilgan Plant, located on the northern side of the Pilgangoora area and produces spodumene and tantalite concentrates, and the Ngungaju Plant is located to the south produces spodumene concentrate. The company owns 70% of the Mt Francisco project, which is located 50 km south-west of the Pilgangoora Project and hosts the large occurrence of outcropping pegmatites located nearby to Port Hedland. The company is also pursuing a proposed downstream joint venture (JV) for the development of an approximately 43,000 tons per annum lithium carbonate equivalent (LCE) lithium chemical conversion facility in South Korea.

📊 Share price

$4.67 AUD

NULL RESOURCES

Want more shares? Try these...

Boss Energy Ltd. engages in the exploration of gold and uranium projects. The company is headquartered in Subiaco, Western Australia. The company went IPO on 2007-07-25. The Company’s Honeymoon Uranium project is located approximately 80 kilometer (km) north-west of the town of Broken Hill, near the border with New South Wales. The Honeymoon Uranium project is targeting the greenfield exploration prospects to further advance identified zones of potential high-grade mineralization. Honeymoon Uranium project is also upgrading the satellite Joint Ore Reserves Committee (JORC) resources of the Jason’s and Gould’s Dam Deposits.

📊 Share price

$2.76 AUD

Bod Science Ltd. operates as a developer, manufacturer, distributor, importer, exporter and marketer of skincare, beauty, and health industries for the natural segment of the market. The company is headquartered in Sydney, New South Wales. The company went IPO on 2016-10-27. The firm is engaged in the development and manufacture of cannabidiol (CBD) and hemp products for consumer markets in Australia, United Kingdom, Europe and United States, as well as the development, manufacture and distribution of therapeutics medicinal cannabis products. The firm operates through three segments: medical, over the counter cannabidiol/Hemp (OTC CBD/Hemp) and OTC Herbals. The firm is developing research and development (R&D) and a defined clinical trial pathway to commercialize and deliver premium, scientifically products for the consumer and medical markets.

📊 Share price

$0.05 AUD